Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells

European Journal of Immunology

Volumn 28, Issue 3, 1998, Pages 780-786

  Lang, Stephan ^a,b   Vujanovic, Nikola L ^b,c   Wollenberg, Barbara ^a   Whiteside, Theresa L ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

B7.1 expression; CD80; Co stimulation; NK cell

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CARCINOMA, SQUAMOUS CELL; CYTOTOXICITY, IMMUNOLOGIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; TUMOR CELLS, CULTURED;

EID: 0031930432     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199803)28:03<780::AID-IMMU780>3.0.CO;2-8     Document Type: Article

References (27)

1. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191.
2. Whiteside, T. L. and Herberman, R. B., Characteristics of natural killer cells and lymphokine activated killer cells. Hum. Cancer Immunol. 1990. 10: 663-670.
3. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-118.
4. Montel, A. H., Morse, P. A. and Brahmi, Z., Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility of lysis by a human NK-like cell line. Cell Immunol. 1995. 160: 104-114.
5. Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, S., Gatti, E., Tornaghi, P., Freschi, M., Forni, G., Dellabona, P. and Casorati, G., Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 1995. 25: 1154-1162.
6. Chambers, B. J., Salcedo, M. and Ljunggren, H.-G., Triggering of Natural killer cells by the costimulatory molecule CD80 (B7.1). Immunity 1996. 5: 311-317.
7. Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I. and Pardoll, D. M., A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 1995. 182: 1415-1421.
8. Yeh, K. Y, Pulaski, B. A., Woods, M. L., McAdam, A. J., Gaspari, A. A., Frelinger, J. G. and Lord, E. M., B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell. Immunol. 1995. 165: 217-224.
9. Geldhof, A. B., Raes, G., Bakkus, M., Devos, S., Thielemans, K. and De Baetselier, P., Expression of B7-1 highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 1995. 5: 2730-2733.
10. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H. and Lanier, L. L., Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 1992. 149: 1115-1123.
11. Roger, R., Breard, J., Comisso, M., Bohuon, C., Pallardy, M. and Bertoglio, J., CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. Cell. Immunol. 1996. 168: 24-32.
12. Nandi, D., Gross, J. A. and Allison, J. P., CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 1994. 152: 3361-3369.
13. Vujanovic, N. L., Nagashima, S., Herberman, R. B. and Whiteside, T. L., Non-secretory apoptotic killing by human natural killer cells. J. Immunol. 1996. 157: 1117-1126.
14. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J. and Nadler, L. M., Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994. 84: 3261-3282.
15. Bretscher, P. and Cohn, M., A theory of self-nonself discrimination. Science 1970. 169: 1042-1049.
16. + cells by B7-transduced melanoma cells. Science 1993. 259: 368-370.
17. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 1994. 15: 321-331.
18. Shindo, T., Sugie, K., Nakamura, K., Tagaya, Y., Maeda, M., Uchiyama, T., Sagawa, K., Yokoyama, M., Wada, H., Hitomi, S. and Yodoi, J., Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70). Immunology 1990. 71: 63-69.
19. Reichert, T. E., Rabinowich, H., Johnson, J. T. and Whiteside, T. L., Human immune cells in the tumor microenvironment: mechanisms responsible for signaling and functional defects. J. Immunotherapy, In press, 1997.
20. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 1993. 177: 1791-1796.
21. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A., CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991. 174: 561-569.
22. Heo, D. S., Snyderman, C., Gollin, S. M., Pan, S., Walker, E., Deka, R., Barnes, E. L., Johnson, J. T., Herberman, R. B. and Whiteside, T. L., Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 1989. 49: 5167-5175.
23. Vujanovic, N. L., Rabinowich, H., Lee, Y. J., Jost, L., Herberman, R. B. and Whiteside, T. L., Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell. Immunol. 1993. 151: 133-157.
24. Zitvogel, L., Robbins, P., Storkus, W., Clarke, M., Maeurer, M., Campbell, R., Davis, C., Tahara, H., Schreiber, R. and Lotze, M., Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol. 1996. 26: 1335-1341.
25. Nolan, G. P., Fiering, S., Nicolas, J. F. and Herzenberg, L. A., Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA 1988. 85: 2603-2607.
26. Pross, H. F., Baines, M. G., Rubin, P., Shragge, P. and Patterson, M. S., Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J. Clin. Immunol. 1981. 1: 51-63.
27. Heo, D. S., Park, J.-G., Hata, K., Day, R., Herberman, R. B. and Whiteside, T. L., Evaluation of tetrazolium-based semi-automatic colorimetric assay for measurement of antitumor cytotoxicity. Cancer Res. 1990. 50: 3681-3690.